Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ABL1 |
Variant | D276G |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | ABL1 D276G lies within the protein kinase domain of the Abl1 protein (UniProt.org). D276G results in increased kinase activity in an in vitro assay and has been demonstrated to occur as a secondary resistance mutation in the context of BCR-ABL (PMID: 15510211), and therefore, is predicted to lead to a gain of Abl1 protein function. |
Associated Drug Resistance | Y |
Category Variants Paths |
ABL1 mutant ABL1 act mut ABL1 D276G |
Transcript | NM_005157.6 |
gDNA | chr9:g.130872133A>G |
cDNA | c.827A>G |
Protein | p.D276G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_005157 | chr9:g.130872133A>G | c.827A>G | p.D276G | RefSeq | GRCh38/hg38 |
NM_005157.5 | chr9:g.130872133A>G | c.827A>G | p.D276G | RefSeq | GRCh38/hg38 |
NM_005157.6 | chr9:g.130872133A>G | c.827A>G | p.D276G | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|